Capture‐based next‐generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing

Background Targeted therapies including monoclonal antibodies and small molecule inhibitors have dramatically changed the treatment of cancer over past 10 years. Their therapeutic advantages are more tumor specific and with less side effects. For precisely tailoring available targeted therapies to each individual or a subset of cancer patients, next‐generation sequencing ( NGS ) has been utilized as a promising diagnosis tool with its advantages...